Epicillin: In Vitro Laboratory Studies
- 1 July 1971
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 4 (1) , 44-9
- https://doi.org/10.1128/iai.4.1.44-49.1971
Abstract
A new semisynthetic penicillin, structurally related to ampicillin, has been assigned the generic name epicillin, 6-[ d -2-amino-2-(1, 4-cyclohexadienyl) acetamido]-penicillanic acid. The antimicrobial spectrum and level of activity of epicillin in vitro are similar to those of ampicillin. In studies with recent clinical isolates, these two antibiotics, when compared with carbenicillin, showed consistently higher antimicrobial activity against Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli , and Proteus species. When tested against Pseudomonas aeruginosa isolates, on the other hand, epicillin exhibited a level of intrinsic activity superior to that of ampicillin but less than that of carbenicillin. Epicillin is an amphoteric substance that is sensitive to penicillinase, is acid-stable, and is minimally, but reversibly, bound to human serum protein.Keywords
This publication has 5 references indexed in Scilit:
- New class of semisynthetic penicillins and cephalosporins derived from D-2-(1,4-cyclohexadienyl)glycineJournal of Medicinal Chemistry, 1971
- Clinical pharmacology of the new penicillins: I. The importance of serum protein binding in determining antimicrobial activity and concentration in serumClinical Pharmacology & Therapeutics, 1966
- THE BINDING OF ANTIBIOTICS TO SERUM PROTEINSBritish Journal of Pharmacology and Chemotherapy, 1965
- A New Approach to Studying the Protein-Binding Properties of PenicillinsNature, 1963
- SPECIFIC HAPTEN OF GROUP C (GROUP-II ALPHA) MENINGOCOCCUS .1. PREPARATION AND IMMUNOLOGICAL BEHAVIOR1958